Nuva
-
Financial
NuVasive Shares Up 6% As Q2 Results Top Estimates, Boosts 2014 Outlook
Shares of NuVasive, Inc. (NUVA: Quote) surged nearly six in extended trading on Tuesday after the medical devices company reported results for the…
Read More » -
Spine
NuVasive(R) Names Carol Cox Executive Vice President Strategy and Corporate Communications
SAN DIEGO, CA–(Marketwired – July 07, 2014) – NuVasive, Inc. (NASDAQ: NUVA), announced today that Carol Cox has joined the…
Read More » -
Spine
NuVasive Announces the Release of the Next Generation Monitoring Platform for Spine Surgery
SAN DIEGO, CA–(Marketwired – June 23, 2014) – NuVasive, Inc. (NASDAQ: NUVA), a medical device company focused on developing minimally…
Read More » -
NuVasive(R) Announces Favorable Resolution of Patent Lawsuit Against Cadwell Laboratories, Inc.
SAN DIEGO, CA — (Marketwired) — 05/06/14 — NuVasive, Inc. (NASDAQ: NUVA), a medical device company focused on developing minimally disruptive surgical products and…
Read More » -
Spine
Federal Jury Awards $30 Million To Nerve Surveillance Device Manufacturer In Dispute Against NuVasive, Inc. (NUVA)
Los Angeles, April 3, 2014 – A federal jury awarded $30 million yesterday in a trademark infringement case brought by…
Read More » -
Spine
JURY FINDS NUVASIVE INFRINGES 3 MEDTRONIC PATENTS, AWARDS MEDTRONIC $101.2M IN DAMAGES; MAINTAIN HOLD AND $22.50 PT
JURY FINDS NUVASIVE INFRINGES 3 MEDTRONIC PATENTS, AWARDS MEDTRONIC $101.2M IN DAMAGES; MAINTAIN HOLD AND $22.50 PT Click Here for…
Read More » -
Spine
NuVasive Announces Jury Verdict in Patent Case
NuVasive, Inc. (NASDAQ: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine,…
Read More » -
Jury Awards Medtronic $101 Million In Patent Suit Against NuVasive
MEMPHIS, TENN. – Sept. 20, 2011 – Medtronic, Inc. (NYSE: MDT) announced today that a jury in the United States District Court…
Read More » -
Uncategorized
Judge nixes Medtronic, NuVasive motions in patent infringement case
A federal judge in California dealt blows to both sides in a patent infringement dispute over spinal implant technology between…
Read More » -
Spine
NuVasive Announces Insurance Coverage Policy Change Regarding XLIF(R) Procedure
NuVasive, Inc. (NASDAQ: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine,…
Read More » -
Jefferies Remains Positive On NUVA, Lowers PT To $34 From $36
Despite near-term challenges and uncertainty in the spine market, Jefferies said that it remains positive on the NuVasive, Inc. (NASDAQ: NUVA)…
Read More » -
Biologics
Advanced BioHealing Appoints Kevin C. O’Boyle as Chief Financial Officer
WESTPORT, Conn., Dec. 10, 2010 /PRNewswire/ — Advanced BioHealing, Inc. (ABH), a leader in commercializing cell-based therapies and delivering on the promise of regenerative…
Read More » -
Spine
Competition To Increase in the $740 Million Minimally Invasive Spinal Fusion Market
TORONTO, Dec. 8, 2010 /PRNewswire/ — According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, competition will…
Read More » -
NuVasive Poised For Strong Results
Nuvasive Inc. (NYSE: NUVA) plans on holding an analyst meeting on September 14. According to Jefferies, while there may be doubt…
Read More » -
NuVasive Reports Second Quarter 2010 Financial Results
SAN DIEGO, CA, Jul 27, 2010 (MARKETWIRE via COMTEX) — NuVasive, Inc. (NASDAQ: NUVA) -- Total revenue of $119.6 million,…
Read More »